Sen. Charles Grassley, R-Iowa, issued letters calling for 33 medical advocacy groups to disclose their financial relationships with device firms and drugmakers to determine whether industry funding influences their lobbying. A spokesman for the American Medical Association said the group will answer Grassley's letter, while a representative for the American Cancer Society said the group "holds itself to the highest standards of transparency and public accountability, and we look forward to working with Senator Grassley to provide the information he requested."

Full Story:

Related Summaries